Industry veteran David Dodd, chairman and CEO at GeoVax, answers questions about the fundraising environment for small biotechs and the dangers of toxic warrants.
We’ve arrived at a critical window for innovation in rare disease that must be treated with the same caliber and urgency that we saw nearly three years ago at the onset of the COVID-19 pandemic.
Corner Therapeutics is focused on discovering new small molecules that could mimic the body’s natural immune response to generate the robust T cell response.
We don’t have to wait for federal guidance, additional DHT, or new innovations. We have the tools to begin to address the lack of trust and limited data and incorporate them into diversity plans for clinical trials today. Here's how.
Regardless of phase, media and mixing optimization can afford operators speed and efficiency for drug processing; likewise, failing to prioritize media preparation can compromise a process.
Microencapsulation, wherein particles are co-formulated with polymers or other excipients to improve palatability, modify release rate, or enhance bioavailability, possesses advantages for many pharmaceutical applications.
The supply chain disruptions to electronic components have caused challenges to the production of medical devices. Companies have had to become creative and versatile to deliver high-quality products.
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.
Connect With Life Science Leader:
This website uses cookies to ensure you get the best experience on our website. Learn more
